RecruitingNot Applicable

Primary Tumor Resection for M1a Stage Lung Cancer

China66 participantsStarted 2024-04-01

Plain-language summary

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1023. This study aims to explore the safety and efficacy of primary lesion resection in the treatment of M1a stage lung cancer with pleural dissemination found during surgery, and to more accurately evaluate whether primary lesion resection can improve the OS and quality of life of the corresponding patients.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Volunteer to participate in clinical research, willing to follow and able to complete all trial procedures;
✓. Aged 18-80 years (including critical values) when signing the informed consent form;
✓. ECOG score 0 or 1;
✓. No previous lung cancer surgery;
✓. Intraoperative or postoperative pathological confirmation of M1a stage lung cancer;
✓. Occult pleural metastasis found during surgery;
✓. Preoperative lymph node staging is cN0;
✓. First-time treatment and no radiotherapy or chemotherapy.

Exclusion criteria

✕. The lesion cannot be completely removed surgically;
✕. Cytological or histological pathology confirms other lung malignancies other than lung cancer;
✕. Patients who have undergone lung cancer surgery before;
✕. Patients who have received radiotherapy or chemotherapy and are not treatment-naive patients.

What they're measuring

Median overall survival

Timeframe: About 10months.

Trial details

NCT IDNCT06547710

SponsorFudan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12

Contact for this trial

Fangqiu Fu, MD

021-64175590 fufangqiu12@163.com

View on ClinicalTrials.gov More Lung Cancer Metastatic trials